US HB1614 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Republican 5-3)
Status: Introduced on March 7 2019 - 25% progression, died in committee
Action: 2019-04-12 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 7 2019 - 25% progression, died in committee
Action: 2019-04-12 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV. Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
Title
John S. McCain Opioid Addiction Prevention Act
Sponsors
| Rep. John Katko [R-NY] | Rep. Thomas Suozzi [D-NY] | Rep. Dean Phillips [D-MN] | Rep. Chris Collins [R-NY] |
| Rep. Suzanne Lee [D-NV] | Rep. Carol Miller [R-WV] | Rep. Susan Brooks [R-IN] | Rep. Guy Reschenthaler [R-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-04-12 | House | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. |
| 2019-03-08 | House | Referred to the Subcommittee on Health. |
| 2019-03-07 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-03-07 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2019-03-07 | House | Introduced in House |
Same As/Similar To
SB724 (Same As) 2019-03-07 - Read twice and referred to the Committee on the Judiciary.
Subjects
Crime and law enforcement
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health personnel
Licensing and registrations
Prescription drugs
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health personnel
Licensing and registrations
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/1614/all-info |
| Text | https://www.congress.gov/116/bills/hr1614/BILLS-116hr1614ih.pdf |
